Global Drug Facility Annual Report 2011 [.pdf] - Stop TB Partnership

More documents

Recommendations

Info

26 GLOBAL DRUG FACILITY Manufacturers’ meetings In 2011, GDF convened manufacturers’ meetings in China and India. The meetings with manufacturers and all partners interested in TB served to galvanize attention on issues around quality assurance and procurement. The meetings additionally brought together stakeholders able collectively to address market dynamic problems with SLDs. Both countries have the potential to make a global contribution to the TB drug market, but many challenges remain. The cost of obtaining prequalification to produce TB drugs is high, demand is uncertain and the small market for drugs – particularly to treat drug-resistant TB – makes it difficult for companies to turn a profit. Priority actions highlighted at both meetings included consolidating demand for drug ingredients and formulations, increasing the number of patients put on treatment in order to reduce the price of drugs and reforming processes to make the market more attractive for manufacturers. The meetings represented an important step towards strengthening the capacity of China and India to produce quality-assured anti-TB drugs.
27 ANNUAL REPORT 2011 Key performance indicators (KPIs) In 2011, GDF developed a series of key performance indicators. The indicators that will be used to measure performance in 2012 are presented in Annex 1.
Page 1 and 2: GLOBAL DRUG FACILITY ANNUAL REPORT
Page 3 and 4: Contents 02 | About the Global Drug
Page 5 and 6: 03 ANNUAL REPORT 2011 Message from
Page 7 and 8: 05 ANNUAL REPORT 2011 GDF was estab
Page 9 and 10: 07 ANNUAL REPORT 2011 Commodity exp
Page 11 and 12: 9 ANNUAL REPORT 2011 2010 GDF Grant
Page 13 and 14: 11 ANNUAL REPORT 2011 Historical an
Page 15 and 16: 13 ANNUAL REPORT 2011 80 70 60 Proc
Page 17 and 18: 15 ANNUAL REPORT 2011 2010 2011 Fre
Page 19 and 20: 17 ANNUAL REPORT 2011 There were ot
Page 21 and 22: 19 ANNUAL REPORT 2011 Diagnostics I
Page 23 and 24: 21 ANNUAL REPORT 2011 First-line dr
Page 25 and 26: 23 ANNUAL REPORT 2011 MDR-TB throug
Page 27: 25 ANNUAL REPORT 2011 Stockpile In
Page 31 and 32: 29 ANNUAL REPORT 2011 Review • An
Page 33 and 34: 31 ANNUAL REPORT 2011 Monitoring mi
Page 35 and 36: 33 ANNUAL REPORT 2011 Annex 2 Patie
Page 37 and 38: 35 ANNUAL REPORT 2011 Country 2011
Page 39 and 40: 37 ANNUAL REPORT 2011 Country Suppl
Page 41 and 42: 39 ANNUAL REPORT 2011 WHO Region Co
Page 43 and 44: 41 ANNUAL REPORT 2011 Annex 5 GeneX
Page 45 and 46: 43 ANNUAL REPORT 2011 Countries rev
Page 48: Stop TB Partnership www.stoptb.org

Global Drug Facility Annual Report 2011 [.pdf] - Stop TB Partnership

Create successful ePaper yourself

Delete template?

Save as template?